multiple myeloma

Rendering of an immune cell
Biotech

ASH: Gilead-Arcellx data build CAR-T's case in advanced myeloma

Arcellx's new data on a Gilead-partnered CAR-T show durable results and best-in-class potential for advanced multiple myeloma, analysts said.
Gabrielle Masson Nov 5, 2024 3:08pm
An imaginary winners podium is modelled and rendered

Trispecific antibody one-ups Tecvayli in myeloma mouse study

Sep 17, 2024 3:38pm
Graphic image of a red thumbs down against a blue background

FDA rejects Regeneron bispecific, delaying rival to J&J, Pfizer

Aug 21, 2024 5:48am
pivot change turnaround direction walk away

BMS axes bispecific months after filing to run phase 3 trial

Jul 26, 2024 8:17am
multiple myeloma cells blood flow cancer blood cancer

AACR: Regeneron's multiple myeloma drug shows staying power

Apr 7, 2024 4:00pm
mountain climb steep challenge point path red flag

Regeneron seeks clarity on confirmatory trials after FDA hurdle

Mar 29, 2024 5:00am